COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Authors
Keywords
SARS-CoV-2, COVID-19, Outpatients, Zinc, Hydroxychloroquine, Azithromycin
Journal
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 56, Issue 6, Pages 106214
Publisher
Elsevier BV
Online
2020-10-27
DOI
10.1016/j.ijantimicag.2020.106214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Viral load of SARS-CoV-2 in clinical samples
- (2020) Yang Pan et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
- (2020) Lirong Zou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis
- (2020) Harvey A Risch AMERICAN JOURNAL OF EPIDEMIOLOGY
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- (2020) B. Coutard et al. ANTIVIRAL RESEARCH
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
- (2020) Andrea Giacomelli et al. CLINICAL INFECTIOUS DISEASES
- Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms
- (2020) Andrea Lovato et al. ENT-EAR NOSE & THROAT JOURNAL
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The SARS-CoV-2 outbreak: What we know
- (2020) Di Wu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
- (2020) Bo Yu et al. Science China-Life Sciences
- Repurposing antimalarials and other drugs for COVID-19
- (2020) Patricia Schlagenhauf et al. Travel Medicine and Infectious Disease
- Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
- (2020) Matthieu Million et al. Travel Medicine and Infectious Disease
- Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
- (2020) Tao Chen et al. BMJ-British Medical Journal
- Management of acute kidney injury in patients with COVID-19
- (2020) Claudio Ronco et al. Lancet Respiratory Medicine
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) The Lancet Editors LANCET
- Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) Mandeep R Mehra et al. LANCET
- In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
- (2020) Julien Andreani et al. MICROBIAL PATHOGENESIS
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
- (2020) R. Derwand et al. MEDICAL HYPOTHESES
- The Role of Zinc in Antiviral Immunity
- (2019) Scott A Read et al. Advances in Nutrition
- Primary care risk stratification in COPD using routinely collected data: a secondary data analysis
- (2019) Matthew Johnson et al. npj Primary Care Respiratory Medicine
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- (2017) Caroline Gordon et al. RHEUMATOLOGY
- Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone
- (2014) Anil Pareek et al. CURRENT MEDICAL RESEARCH AND OPINION
- Chloroquine Is a Zinc Ionophore
- (2014) Jing Xue et al. PLoS One
- Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
- (2014) Jean Kaoru Millet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial
- (2013) Alicia M Fry et al. LANCET INFECTIOUS DISEASES
- Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapy
- (2012) L. A. Braun et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals
- (2012) Emileigh Mercer et al. ARTHRITIS RESEARCH & THERAPY
- Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection
- (2010) R. Zarychanski et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
- (2010) Aartjan J. W. te Velthuis et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now